Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-25

Clinical Trial Update: Dietary Supplementation With Low-Dose Omega-3 Reduces Salivary TNF-α Levels in Patients With Chronic Periodontitis [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study in chronic periodontitis found that low-dose omega-3 supplementation reduced salivary TNF-α levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: İlker KESKINER | Conditions: Chronic Periodontitis | EARLY_Phase 1 | Status: COMPLETED